Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Serotype A for Cervicobrachial Myofascial Syndrome
NCT00241215Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2003
- Primary completion
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myofascial pain syndrome (MPS) and cervicobrachial neuralgia comparing Botox Group with Placebo Group (2 arms). Primary endpoints: Numerical Pain Rating, Brief Pain Inventory and 4 more. Started Jun 2003; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)cervicobrachial neuralgia
Beyond the preview
Go deeper on NCT00241215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241215.